Cellectis S.A. (NASDAQ:CLLS) Q3 2024 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Cellectis Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Cellectis S.a. (CLLS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 27,624 | $59,115 | +4% | 0% |
| 2. | 5,900 | $12,626 | +111% | 0% | |
| 3. | 1,400 | $2,996 | +28% | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,487,293 | $13,820,862 | 0.45% | |
| 2. | 1,848,804 | $5,694,316 | 0% | |
| 3. | 1,438,255 | $4,429,825 | 0% | |
| 4. | 816,643 | $2,515,261 | 0% | |
| 5. | 399,627 | $1,230,851 | 0% |
News See All
Cellectis S.A. (NASDAQ:CLLS) Q3 2024 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Cellectis Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Cellectis S.A. (NASDAQ:CLLS) Q1 2024 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Cellectis First Quarter 2024 Earnings Call. [Operator Instructions] Please be aware that today's conference call is being recorded.
Cellectis S.A. (NASDAQ:CLLS) Q3 2023 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Cellectis Third Quarter 2023 Earnings Calls. [Operator Instructions].
Cellectis S.A. (NASDAQ:CLLS) Q2 2023 Earnings Call Transcript
Operator: Good morning, and everyone, welcome to Cellectis Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Cellectis S.A. (NASDAQ:CLLS) Q1 2023 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to Cellectis First quarter 2023 Earnings Call. [Operator Instructions]. Please be aware that today's conference call is being recorded.
Cellectis S.A. (NASDAQ:CLLS) Q4 2022 Earnings Call Transcript
Operator: Good morning, everyone and welcome to Cellectis Fourth Quarter and Full Year 2022 Earnings Conference Call. Please be aware that today's conference call is being recorded.
10 Genomics Stocks in Cathie Wood's Portfolio That Are Underperforming
In this article, we discuss 10 genomics stocks in Cathie Wood’s portfolio that are underperforming.
15 Worst Stock Picks of Cathie Wood
Cathie Wood, the chief ARK Investment Management, is often hailed as the champion of “disruptive innovation” at the stock market.
10 Best Biotech Stocks Under $20 in Cathie Wood's Portfolio
In this article, we discuss the 10 best biotech stocks under $20 in Cathie Wood's portfolio.